Trial Profile
Effects of Linagliptin on active GLP-1 concentrations in subjects with renal impairment
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 03 Oct 2021
Price :
$35
*
At a glance
- Drugs Linagliptin (Primary)
- Indications Type 2 diabetes mellitus
- Focus Pharmacodynamics
- 02 May 2016 Status changed from active, no longer recruiting to completed.
- 23 Feb 2016 Planned End Date changed from 1 Jan 2016 to 1 Jun 2016, according to ClinicalTrials.gov record.
- 23 Feb 2016 Planned primary completion date changed from 1 Jan 2016 to 1 Jun 2016, according to ClinicalTrials.gov record.